ECMC Network
@ecmc_uk
Experimental Cancer Medicine Centres develop new cancer therapies. Jointly funded @CR_UK @LPTrustUK @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust
ID: 1903979808
http://www.ecmcnetwork.org.uk/ 25-09-2013 12:11:12
6,6K Tweet
3,3K Followers
1,1K Following
Emma Williams, part of our ECMC nursing steering committee, was Chief Investigator on a study published in RCNi: the life-long learning partner for nurses. It investigated the quality of life of people affected by relapsed/refractory diffuse large B-cell #Lymphoma undergoing #CAR-T cell therapy 👉bit.ly/4esNsen
Hearing from Prof James Spicer & Linda Gomm King's College London Guy's and St Thomas' about the changes in early phase Cancer trials over the past few years and exciting developments coming next & how this impacts research nurses
Explore solutions to common clinical problems in neuro-oncology 🧠. Martin McCabe will chair a discussion providing key insights. Manchester ECMC | #ESMO2024 | The Christie NHS
More from Martin McCabe Join us as he chairs a session outlining findings from the EORTC-SPECTA proof-of-concept study and explore comprehensive molecular profiling in AYA #cancer patients Manchester ECMC | #ESMO2024 | The Christie NHS
Discover how ePROMs are transforming #ProstateCancer care at Kate O'Connor’s poster presenting real-world experiences with nurse and pharmacist-led telephone clinics📱 Manchester ECMC | #ESMO2024
Learn the latest real-world treatment and survival insights for ROS1+ NSCLC patients with @ECMC_Newcastle co-lead Alastair Greystoke, as he presents recent data. #ESMO2024 |Alastair Greystoke
Some great research presented by our KHP ECMC co-lead! King's Health Partners | #ESMO2024
Join Bernadett Szabados to discuss challenges in the treatment of urothelial and renal cell carcinomas Barts Experimental Cancer Medicine Centre | Bernadett Szabados
Hear the latest results on the efficacy and safety of entrectinib in ROS1+ NSCLC with Matthew Krebs. The Christie NHS | Manchester Cancer Research Centre | #ESMO2024
How can we tackle regulatory challenges in clinical cancer drug development? Find out in the session chaired by Ruth Newcastle University Centre for Cancer | Sir Bobby Robson Cancer Trials Research Centre | #ESMO2024 | #CRUKFunded
Great to see more members of the network presenting at #ESMO2024 Liverpool ECMC | Christian Ottensmeier